Φορτώνει......
A case of large-cell lung carcinoma successfully treated with pembrolizumab but complicated with cholangitis
Large-cell carcinoma (LCC) of the lung is defined as an undifferentiated non-small cell lung cancer (NSCLC) and accounts for approximately 7.5% of lung cancers. Immune checkpoint inhibitors (ICIs) may be effective for LCC, but there has been no firm evidence due to its low frequency. We herein repor...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Respir Med Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7481563/ https://ncbi.nlm.nih.gov/pubmed/32944497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101197 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|